David Fajgenbaum is a physician-scientist at the University of Pennsylvania, Founding Director of the Center for Cytokine Storm Treatment & Laboratory (CSTL), Associate Director of the Penn Orphan Disease Center, and Co-Founder & President of the Castleman Disease Collaborative Network (CDCN). He is also the national bestselling author of ‘Chasing My Cure: A Doctor’s Race to Turn Hope Into Action‘ and a patient battling idiopathic multicentric Castleman disease (iMCD). He is in his longest remission ever thanks to a precision treatment that he identified, which had never been used before for iMCD. An authority on cytokine storms and their treatment, Fajgenbaum leads over 20 translational research studies including the CORONA Project, which is the world’s largest effort to identify, track, and advance COVID-19 treatments.
Fajgenbaum has published scientific papers in high-impact journals such as the New England Journal of Medicine, Journal of Clinical Investigation, and Lancet. He currently serves on the Board of Directors for the Reagan-Udall Foundation for the FDA, Co-Chair of the Advisory Board for the CURE Drug Repurposing Collaboratory, and Co-Chair of the Scientific Advisory Board for the CDCN. Dr. Fajgenbaum earned a B.S. from Georgetown University, M.Sc from the University of Oxford, M.D. from the University of Pennsylvania, and MBA from The Wharton School.
